General Internal Medicine Fellowship in Medication Use and Outcomes
|
| ||
The Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women’s Hospital, Harvard Medical School, seeks applicants for a General Internal Medicine Fellowship to focus on studies of medication prescribing, use, and outcomes. Subtopics will include comparative effectiveness research, drug and device safety/cost-effectiveness research, intersections between laws and regulations and delivery of therapeutics, and the development and evaluation of innovative programs to improve prescribing.
The Division is a close-knit 60-member interdisciplinary research program on the HMS-Brigham campus (see www.DrugEpi.org). Its faculty members focus on rigorously defining the relationships among the benefits, risks, costs, and regulation of medications and devices, and on studying the effect of each of these on health care delivery and patient outcomes. Fellows’ mentored research will provide them with skills to generate and synthesize evidence on specific medical interventions that will lead to better-informed clinical decisions.
The two-year research-oriented fellowship begins July 1, 2020 and is a component of the Harvard Medical School-wide General Internal Medicine Fellowship Program. Fellows will have the opportunity for limited clinical work. All Fellows are enrolled in the Clinical Effectiveness Program at the Harvard School of Public Health, and most complete an M.P.H. degree during their fellowship.
Prospective applicants should send a CV and letter of interest via e-mail to Aaron Kesselheim, M.D., J.D., M.P.H., Professor of Medicine
([email protected]) by February 14, 2020.
The Division is a close-knit 60-member interdisciplinary research program on the HMS-Brigham campus (see www.DrugEpi.org). Its faculty members focus on rigorously defining the relationships among the benefits, risks, costs, and regulation of medications and devices, and on studying the effect of each of these on health care delivery and patient outcomes. Fellows’ mentored research will provide them with skills to generate and synthesize evidence on specific medical interventions that will lead to better-informed clinical decisions.
The two-year research-oriented fellowship begins July 1, 2020 and is a component of the Harvard Medical School-wide General Internal Medicine Fellowship Program. Fellows will have the opportunity for limited clinical work. All Fellows are enrolled in the Clinical Effectiveness Program at the Harvard School of Public Health, and most complete an M.P.H. degree during their fellowship.
Prospective applicants should send a CV and letter of interest via e-mail to Aaron Kesselheim, M.D., J.D., M.P.H., Professor of Medicine
([email protected]) by February 14, 2020.
Brigham and Women’s Hospital and Harvard Medical School are Equal Opportunity/Affirmative Action Employers; women and members of underrepresented minority groups are strongly encouraged to apply.
